{"id":70740,"date":"2026-05-12T10:25:30","date_gmt":"2026-05-12T10:25:30","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70740"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"ghrp-2","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/ghrp-2\/","title":{"rendered":"Acetato de GHRP-2"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 o Acetato de GHRP-2?<\/h3>\n<p style=\"margin: 0;\"><strong>Acetato de GHRP-2<\/strong> (tamb\u00e9m chamado Pralmorelin ou KP-102) \u00e9 um hexapept\u00eddeo sint\u00e9tico de 6 amino\u00e1cidos, secretagogo da hormona de crescimento, e o membro mais potente da primeira gera\u00e7\u00e3o da s\u00e9rie GHRP por mg. Atua no recetor secretagogo da hormona de crescimento (GHS-R1a) \u2014 o mesmo recetor que a grelina end\u00f3gena e como <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a> \u2014 producing pulsatile GH release with a smaller appetite signal than GHRP-6 but a similar cortisol\/prolactin profile. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">158861-67-7 (base livre de GHRP-2); fornecido na forma de sal de acetato<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>45<\/sub>H<sub>55<\/sub>N<sub>9<\/sub>O<sub>6<\/sub> (base livre; sal de acetato adiciona CH<sub>3<\/sub>Contrai\u00e3o COOH)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">817.97 Da (base livre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub> (6 amino\u00e1cidos; cont\u00e9m D-Ala na posi\u00e7\u00e3o 1, D-2-naftilalanina na posi\u00e7\u00e3o 2 e D-Phe na posi\u00e7\u00e3o 5 para estabilidade proteol\u00edtica; C-terminalmente amidado). Tamb\u00e9m conhecido como Pralmorelin \/ KP-102.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sal de acetato liofilizado (p\u00f3 branco a branco-acinzentado)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 o Acetato de GHRP-2?<\/h2>\n<p><strong>GHRP-2<\/strong> (Pept\u00eddeo Libertador da Hormona de Crescimento 2), tamb\u00e9m conhecido como <strong>Pralmorelin<\/strong> ou pelo seu c\u00f3digo de desenvolvimento original <strong>KP-102<\/strong>, is a 6-amino-acid synthetic hexapeptide and one of the canonical first-generation members of the growth hormone secretagogue (GHS) peptide class. It was developed shortly after GHRP-6 in the same Bowers structure-activity-relationship programme at Tulane University, with a focus on increasing per-mg potency relative to the parent compound while preserving the GHS-R1a-selective receptor profile. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and aqueous solubility without altering pharmacology. The well-characterised sequence is D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub>, peso molecular 817,97 Da, f\u00f3rmula emp\u00edrica C<sub>45<\/sub>H<sub>55<\/sub>N<sub>9<\/sub>O<sub>6<\/sub>. The structural innovation relative to GHRP-6 is the introduction of D-2-naphthylalanine (D-2-Nal) at position 2 in place of D-Trp \u2014 the more lipophilic naphthyl ring increases GHS-R1a affinity and produces approximately 2\u20133-fold greater per-mg GH-releasing potency in published studies. The two D-amino-acid substitutions (D-Ala at position 1, D-Phe at position 5) confer protease resistance. Notably, in Japan GHRP-2 (under the name Pralmorelin Hydrochloride \/ GHRP Kaken) was approved as a single-use intravenous diagnostic agent for adult growth hormone deficiency testing \u2014 one of the only GHS peptides to reach any form of clinical approval. GHRP-2 remains <strong>aprovado<\/strong> by the FDA, EMA, MHRA, or any other Western regulator for therapeutic use. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Agonismo do Recetor GHS-R1a com Pot\u00eancia Aumentada<\/h2>\n<p>O que torna o GHRP-2 mecanicamente distintivo entre os secretagogos da hormona de crescimento de primeira gera\u00e7\u00e3o \u00e9 a combina\u00e7\u00e3o de <strong>alta afinidade ao GHS-R1a com uma meia-vida plasm\u00e1tica relativamente curta<\/strong>, producing a sharper and more reproducible GH pulse in published studies:<\/p>\n<ul>\n<li><strong>Agonismo do recetor GHS-R1a nos somatotrofos<\/strong> \u2014 O GHRP-2 liga-se ao recetor secretagogo da hormona de crescimento tipo 1a (GHS-R1a, o recetor da grelina) nos somatotr\u00f3ficos da hip\u00f3fise anterior. A ativa\u00e7\u00e3o do recetor acopla-se ao G\u03b1<sub>q\/11<\/sub> e \u00e0 fosfolipase C, aumentando o c\u00e1lcio intracelular e desencadeando a exocitose de ves\u00edculas contendo GH. A substitui\u00e7\u00e3o de D-2-Nal na posi\u00e7\u00e3o 2 produz aproximadamente 2\u20133 vezes maior ocupa\u00e7\u00e3o do recetor em doses equivalentes em compara\u00e7\u00e3o com o GHRP-6 em ensaios de liga\u00e7\u00e3o de radioligandos, traduzindo-se num pulso de GH maior por unidade de dose.<\/li>\n<li><strong>Supress\u00e3o do t\u00f3nus de somatostatina<\/strong> \u2014 Como outros GHRPs, o GHRP-2 atua tanto nos somatotr\u00f3ficos como nos neur\u00f3nios hipotal\u00e2micos que libertam somatostatina. Ao suprimir a inibi\u00e7\u00e3o t\u00f3nica da somatostatina simultaneamente com a estimula\u00e7\u00e3o da liberta\u00e7\u00e3o dos somatotr\u00f3ficos, o pept\u00eddeo produz um pulso l\u00edquido de GH maior do que a estimula\u00e7\u00e3o direta da hip\u00f3fise sozinha preveria. Esta a\u00e7\u00e3o dupla \u00e9 o mecanismo can\u00f3nico da classe GHRP e est\u00e1 na base da sinergia com os an\u00e1logos de GHRH descritos abaixo.<\/li>\n<li><strong>Sinergia com agonistas do recetor de GHRH<\/strong> \u2014 As vias GHS-R e GHRH-R convergem intracelularmente, mas utilizam diferentes sistemas de segundos mensageiros (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> vs adenylyl cyclase\/cAMP\/PKA), so GHRP-2 and GHRH analogs produce additive or synergistic GH release when combined. The canonical protocol pairs GHRP-2 with a GHRH analog such as <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> for maximal pulsatile GH studies stimulus. The &#8220;GHRP-2 + GHRH&#8221; challenge is also the basis for the Japanese clinical use of Pralmorelin in GH-deficiency diagnostic testing.<\/li>\n<\/ul>\n<p>GHRP-2 produces a smaller appetite signal than GHRP-6 in head-to-head rodent and human studies \u2014 the D-2-Nal substitution at position 2 reduces but does not eliminate the orexigenic activity inherited from ghrelin-receptor agonism. The cortisol and prolactin signals remain present at levels comparable to GHRP-6, which is the principal studies-relevant confound that newer receptor-selective analogs (Ipamorelin) were designed to eliminate. Plasma half-life is approximately 15\u201320 minutes \u2014 shorter than GHRP-6 (~30\u201360 min) \u2014 which produces a sharper and more reproducible GH pulse but requires more frequent dosing for sustained-stimulus protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GHRP-2 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia do eixo da hormona de crescimento<\/strong> \u2014 din\u00e2micas de GH puls\u00e1til, dose-resposta somatotr\u00f3fica, ensaios de pot\u00eancia comparativa de GHS; refer\u00eancia de GHS de primeira gera\u00e7\u00e3o de alta pot\u00eancia na literatura publicada sobre o eixo GH (Bowers, J Clin Endocrinol Metab; Ghigo et al., J Clin Endocrinol Metab)<\/li>\n<li><strong>GH-deficiency diagnostic studies<\/strong> \u2014 testes de estimula\u00e7\u00e3o com GHRP-2 para defici\u00eancia de GH em adultos (o caso de uso cl\u00ednico japon\u00eas), testes combinados de desafio GHRP-2 + GHRH, caracteriza\u00e7\u00e3o da reserva somatotr\u00f3fica em modelos pr\u00e9-cl\u00ednicos<\/li>\n<li><strong>Pituitary function studies<\/strong> \u2014 GH reserve testing, somatotroph hypertrophy \/ hyperplasia, mechanism-of-action data for novel GH secretagogues<\/li>\n<li><strong>Cachexia and wasting syndrome<\/strong> \u2014 caquexia em roedores com tumores, desgaste associado a DPOC, modelos de sarcopenia relacionada com o envelhecimento; o sinal de apetite menor do que o GHRP-6 torna o GHRP-2 \u00fatil quando a ingest\u00e3o de alimentos \u00e9 uma confus\u00e3o<\/li>\n<li><strong>Farmacologia do eixo da grelina<\/strong> \u2014 reduced but non-zero appetite signal; useful arm for separating GHS-R-mediated appetite from GH-axis effects<\/li>\n<li><strong>Comparative GHS studies<\/strong> \u2014 compara\u00e7\u00e3o direta com <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a> (irm\u00e3o de primeira gera\u00e7\u00e3o), <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> (seletivo de recetor de terceira gera\u00e7\u00e3o), hexarelina e GHS pequenas mol\u00e9culas oralmente ativas, como o MK-677<\/li>\n<li><strong>Combined GHRP + GHRH use<\/strong> \u2014 canonical &#8220;GHRP-2 + GHRH&#8221; synergistic protocol for maximal GH-pulse support stimulus, pairing GHRP-2 with <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a>.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde o GHRP-2 se enquadra no panorama de pept\u00eddeos do eixo de crescimento, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a> como o irm\u00e3o da primeira gera\u00e7\u00e3o, <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> como o an\u00e1logo mais recente e seletivo do recetor, e <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> como o parceiro sinerg\u00edstico can\u00f3nico do GHRH. Explore toda a <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks GHRP-2 Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 short-cycle GH-pulse protocols, single-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de ciclo prolongado, estudos de m\u00faltiplas coortes, menor custo por mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols. Because GHRP-2 dose ranges are in the 100\u2013500\u00a0mcg per administration regime, a single 5\u00a0mg vial supports many weeks of use at typical doses. <\/p>\n<h2>Compara\u00e7\u00e3o \u2014 GHRP-2 vs GHRP-6<\/h2>\n<p>GHRP-2 e <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a> are the two canonical first-generation hexapeptide growth hormone secretagogues from the Bowers clinical programme. They share the same receptor (GHS-R1a) and the same six-residue hexapeptide architecture, differing primarily in the amino acid at position 2 \u2014 D-2-naphthylalanine in GHRP-2 versus D-tryptophan in GHRP-6. This single substitution accounts for most of the pharmacological differences observed in published studies. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHRP-2 (Pralmorelina)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHRP-6<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">6 amino\u00e1cidos (hexapept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">6 amino\u00e1cidos (hexapept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Res\u00edduo na posi\u00e7\u00e3o 2<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D-2-naftilalanina (D-2-Nal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D-triptofano (D-Trp)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Pot\u00eancia por mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2\u20133\u00d7 mais potente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pot\u00eancia de base da primeira gera\u00e7\u00e3o<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sinal de apetite<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Reduzida (ainda presente, menor que GHRP-6)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (efeito orexig\u00e9nico semelhante \u00e0 grelina)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cortisol \/ prolactina<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aumentos modestos (compar\u00e1veis ao GHRP-6)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aumentos modestos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201320 min<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30\u201360 min<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500\u00a0mcg, 1\u20133x por dia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013300 mcg, 1\u20133 vezes por dia<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Teste diagn\u00f3stico de defici\u00eancia de GH (apenas no Jap\u00e3o)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nenhum aprovado em qualquer lugar<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies where appetite stimulation is part of the target endpoint (cachexia models, food-intake studies), GHRP-6 is the conventional choice because the orexigenic signal is stronger. For studies where the appetite confound is a concern but cortisol\/prolactin tolerability is acceptable, GHRP-2 produces a sharper GH pulse with less feeding-behaviour interference. For the cleanest possible GH-axis pharmacology where cortisol and prolactin must be controlled, <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> (an\u00e1logo seletivo de terceira gera\u00e7\u00e3o) \u00e9 a alternativa seletiva de recetor. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene os frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para stock de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congele a \u221220 \u00b0C. O acetato de GHRP-2 liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220 \u00b0C por at\u00e9 36 meses. Evite ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose; 0.1\u00a0mL delivers 250\u00a0mcg. Swirl gently \u2014 do <strong>n\u00e3o<\/strong> agite vigorosamente \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve ser l\u00edmpida e incolor. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138\u00a0\u00b0C e utilize dentro de 30 dias para estabilidade \u00f3tima. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is GHRP-2 used for in studies?<\/h3>\n<p>GHRP-2 is used in studies investigating the growth hormone axis, pulsatile GH release dynamics, somatotroph dose-response characterisation, GH-deficiency diagnostic protocols, ghrelin-axis pharmacology, cachexia and wasting syndrome models, and combined GHRP + GHRH synergistic GH-release protocols. It is the most potent first-generation GHS peptide on a per-mg basis. The pharmaceutical-grade GHRP-2 sold here is <strong>n\u00e3o<\/strong> FDA-approved (except for the diagnostic indication in Japan) and is supplied strictly for clinical studies use only. <\/p>\n<h3>Como \u00e9 que o GHRP-2 difere do GHRP-6?<\/h3>\n<p>Ambos s\u00e3o hexap\u00e9ptidos secretagogos da hormona de crescimento de primeira gera\u00e7\u00e3o que atuam no mesmo recetor GHS-R1a, mas diferem no amino\u00e1cido na posi\u00e7\u00e3o 2 \u2014 D-2-naftilalanina no GHRP-2 versus D-triptofano no GHRP-6. Esta \u00fanica substitui\u00e7\u00e3o torna o GHRP-2 cerca de 2\u20133\u00d7 mais potente por mg e produz um sinal de apetite menor. Ambos os p\u00e9ptidos mant\u00eam o modesto sinal de cortisol\/prolactina que os an\u00e1logos seletivos de recetor mais recentes (como o Ipamorelin) foram concebidos para eliminar. A meia-vida plasm\u00e1tica \u00e9 mais curta para o GHRP-2 (~15\u201320 min) em compara\u00e7\u00e3o com o GHRP-6 (~30\u201360 min). <\/p>\n<h3>Qual \u00e9 a diferen\u00e7a entre GHRP-2 e Pralmorelina?<\/h3>\n<p>They are the same compound under different names. &#8220;GHRP-2&#8221; is the studies-literature designation; &#8220;Pralmorelin&#8221; is the international nonproprietary name (INN); &#8220;KP-102&#8221; was the original Kaken Pharmaceutical developmental code. The compound was approved in Japan under the Pralmorelin name as a single-use intravenous diagnostic test for adult growth hormone deficiency \u2014 the only Western-style regulatory approval of any GHRP-series peptide to date. <\/p>\n<h3>What is the typical GHRP-2 dose?<\/h3>\n<p>Published preclinical protocols typically use 100\u2013500\u00a0mcg per administration, given subcutaneously 1\u20133 times daily for 2\u201312 week cycles. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 0.04\u00a0mL equals 100\u00a0mcg, 0.1\u00a0mL equals 250\u00a0mcg. The Japanese diagnostic-test dose is 100\u00a0mcg intravenously as a single administration. <\/p>\n<h3>O GHRP-2 \u00e9 aprovado pela FDA?<\/h3>\n<p>No. GHRP-2 is not approved by the FDA, EMA, MHRA, or any other Western regulator for human therapeutic or diagnostic use. It is approved in Japan under the name Pralmorelin Hydrochloride \/ GHRP Kaken as a single-use intravenous diagnostic agent for adult growth hormone deficiency testing. <\/p>\n<h3>Como deve ser armazenado o Acetato de GHRP-2?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para stock de trabalho a curto prazo, ou \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, utilizar no prazo de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam o p\u00e9ptido. Proteger da luz direta em todos os momentos. <\/p>\n<h3>Como devo reconstituir o GHRP-2?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 clara e incolor. Para um frasco de 5\u00a0mg + 2,0\u00a0mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 2,5\u00a0mg\/mL. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>MedsBase carries GHRP-2 Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Por que \u00e9 o GHRP-2 mais potente do que o GHRP-6?<\/h3>\n<p>The structural difference is the amino acid at position 2 of the hexapeptide \u2014 D-2-naphthylalanine in GHRP-2 versus D-tryptophan in GHRP-6. The naphthyl ring is more lipophilic and slightly larger than the indole ring of tryptophan, producing tighter binding to the hydrophobic pocket of the GHS-R1a receptor. Radioligand-binding assays show approximately 2\u20133-fold higher receptor occupancy at equivalent doses, which translates into a larger GH pulse per unit dose in published preclinical and clinical studies. <\/p>\n<h3>Can GHRP-2 be paired with a GHRH analog in studies?<\/h3>\n<p>Sim \u2014 este \u00e9 o protocolo can\u00f3nico sin\u00e9rgico de pulso de GH e a base do teste cl\u00ednico japon\u00eas de diagn\u00f3stico de defici\u00eancia de GH. O GHRP-2 ativa o GHS-R1a (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> sinaliza\u00e7\u00e3o) enquanto os an\u00e1logos de GHRH como <a href=\"https:\/\/medsbase.com\/pt-pt\/sermorelin\/\">Sermorelin<\/a> ou <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> ativa o GHRH-R (sinaliza\u00e7\u00e3o da adenilil ciclase\/cAMP\/PKA). As duas vias convergem nos somatotrofos mas utilizam sistemas de segundos mensageiros diferentes, produzindo uma liberta\u00e7\u00e3o de GH aditiva ou sin\u00e9rgica quando combinadas. <\/p>\n<h3>Does GHRP-2 cause side reported effects?<\/h3>\n<p>The principal on-target effects are GH release and (modest) appetite stimulation. Off-target findings include modest cortisol and prolactin increases \u2014 the principal studies-relevant confound for clean GH-axis studies \u2014 comparable in magnitude to GHRP-6. Transient flushing or local injection-site reactions are reported. At high doses, GHS-R-mediated effects on cardiac function and blood pressure can be observed. The cortisol\/prolactin signal is the main reason newer-generation selective analogs such as Ipamorelin were developed. <\/p>\n<h3>Qual \u00e9 a meia-vida do GHRP-2?<\/h3>\n<p>In preclinical and clinical studies, GHRP-2 has a plasma half-life of approximately 15\u201320 minutes following subcutaneous or intravenous administration \u2014 somewhat shorter than GHRP-6 (~30\u201360 min). The shorter half-life produces a sharper, more reproducible GH pulse that is useful for diagnostic and dose-response studies, but requires more frequent dosing for sustained-stimulus protocols. <\/p>\n<h3>How long does GHRP-2 take to show effects in preclinical studies?<\/h3>\n<p>Os pulsos agudos de GH s\u00e3o detet\u00e1veis dentro de 10\u201320 minutos ap\u00f3s administra\u00e7\u00e3o subcut\u00e2nea ou intravenosa e atingem o pico em 30\u201345 minutos \u2014 um in\u00edcio mais r\u00e1pido do que com o GHRP-6 devido a uma maior afinidade ao GHS-R1a. Os efeitos de estimula\u00e7\u00e3o do apetite na ingest\u00e3o de alimentos s\u00e3o menores e mais lentos a desenvolver-se do que com o GHRP-6. Os efeitos subsequentes na produ\u00e7\u00e3o de IGF-1 e na sinaliza\u00e7\u00e3o do eixo GH a n\u00edvel dos tecidos acumulam-se ao longo de 1\u20134 semanas de dosagem regular. <\/p>\n<h3>Posso encomendar GHRP-2 para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia GHRP-2 para todo o mundo a partir da nossa rede dedicada de envio de p\u00e9ptidos. As encomendas exclusivas de p\u00e9ptidos qualificam-se para o nosso servi\u00e7o de envio de p\u00e9ptidos independente. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura, com rastreio completo e est\u00e3o cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Growth-Axis, GH-Release, and Anabolic Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/ghrp-6\/\"><strong>GHRP-6<\/strong><\/a> \u2014 Irm\u00e3o hexapept\u00eddico de primeira gera\u00e7\u00e3o \u2014 sinal de apetite mais forte, meia-vida mais longa<\/li>\n<li><a href=\"\/pt-pt\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Pentap\u00e9ptido seletivo GHS de terceira gera\u00e7\u00e3o \u2014 pulso limpo de GH sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-pt\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH de a\u00e7\u00e3o prolongada \u2014 parceiro sinerg\u00e9tico can\u00f3nico de GHRH<\/li>\n<li><a href=\"\/pt-pt\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 Shorter-acting GHRH(1-29) analog \u2014 natural GH-pulse support<\/li>\n<li><a href=\"\/pt-pt\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 An\u00e1logo recombinante de IGF-1 com arginina longa \u2014 a jusante do eixo GH\/IGF<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore o panorama dos p\u00e9ptidos do eixo GH<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos relacionados do eixo GH incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/ghrp-6\/\">GHRP-6<\/a> for first-generation sibling studies, <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin\/\">Ipamorelin<\/a> for clean receptor-selective GHS studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/cjc-1295-with-dac\/\">CJC-1295 com DAC<\/a> for long-acting GHRH use.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Hexapept\u00eddeo GHS de primeira gera\u00e7\u00e3o mais potente<br \/>\n\u2705 Agonista do receptor GHS-R1a \/ receptor de grelina<br \/>\n\u2705 Pulso de GH mais acentuado do que GHRP-6<br \/>\n\u2705 Sinal de apetite menor do que GHRP-6<br \/>\n\u2705 Aprovado como Pralmorelin no Jap\u00e3o para diagn\u00f3stico de defici\u00eancia de GH<\/p>\n<p><strong>Acetato de GHRP-2<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70954,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6281,6283,5441,6282],"class_list":["post-70740","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ghrp-2","product_tag-kp-102","product_tag-peptide","product_tag-pralmorelin","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70954"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70740"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70740"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70740"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}